News for MERCK & CO INC (MRKD.BA)

PR NewswireNEW YORK, July 7, 2025 NetworkNewsWire Editorial CoverageNEW YORK, July 7, 2025 /PRNewswire/ -- An estimated 20 million people are diagnosed ann

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates (newborns) and infants who were born during or entering their first RSV season. To […]

Key Highlights: Merck (MRK) faces potential impacts due to the Biotechnology Innovation Organization's (BIO) stance against RFK Jr. Analysts forecast a p

Merck & Co., Inc. (NYSE:MRK) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company shared encouraging results from its Phase 3 HYPERION trial. The study tested a drug called WINREVAIR (sotatercept-csrk) against a placebo, both combined with standard treatment, in adults recently diagnosed with pulmonary […]

Merck & Co., Inc. (NYSE:MRK) is one of the Best Stocks to Buy for Dividends. Merck & Co., Inc. (NYSE:MRK) is a leading pharmaceutical company, best known for its strong presence in oncology, particularly through Keytruda, the top-selling drug globally. Beyond cancer treatment, the company also produces medications for diabetes, as well as vaccines for […]

Merck's heavy reliance on Keytruda continues to grow, with the drug nearing 50% of total sales and limited growth from other products. Read why MRK is a Buy.

Merck (MRK) revealed that the Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention has voted to endorse Enflonsia

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best and Cheap Stocks to Buy Now. On June 18, Akash Tewari, an analyst from Jefferies, maintained the Buy rating on Merck & Co., Inc. (NYSE:MRK) with a price target of $138. The positive outlook is based on the stability of the company’s vaccine sales and […]

Merck (MRK) has reported promising results from its Phase 3 HYPERION trial, which evaluated the efficacy of WINREVAIR in adults recently diagnosed with pulmonar

Merck (MRK) shows promising results in its Winrevair trial for pulmonary arterial hypertension, signaling potential for reduced health risks. Analysts p

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 HYPERION study evaluating WI

A heated debate over the U.S. healthcare system erupted on X, pitting billionaire entrepreneur Mark Cuban against Sen. Elizabeth Warren (D-Mass) over the root causes of soaring drug prices. What Happened: The clash, unfolding as of Friday, has ...

Abbott and MSD Pharmaceuticals partner to distribute oral anti-diabetic medicines in India, benefiting millions with Type 2 diabetes.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...

Merck & Co., Inc. (NYSE:MRK) is one of Best Dividend Stocks to Buy for Dependable Growth. Merck & Co., Inc. (NYSE:MRK) is one of the best dividend stocks for dependable dividend growth. The company is not only recognized for its strong pipeline but also for its consistent dividend growth. It expects approvals for up to […]

Insights from the First Quarter of 2025 N-PORT Filing Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the first quarter

Key Highlights: The Supreme Court decision paves the way for litigation against Merck involving the drug Fosamax. Analysts predict a potential upside for

Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot received authorization from the U.S. Food and Drug Administration (FDA). This shot shields infants up to the age of one from the respiratory syncytial virus during their first RSV period. RSV refers […]